Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

High-Dimensional Single-Cell Analysis of Clinical-Grade Flow Cytometry Explains the Unpredictable Complex Shifts of Patient-Specific Immunophenotypes during B-ALL Relapse Progression

Nina Rolf, Lorraine YT Liu, Pascal LeClair, Tanmaya Atre, Suzanne Vercauteren, Chinten James Lim, Gregor S. D. Reid

Blood (2024) 144 (Supplement 1): 5928.

https://doi.org/10.1182/blood-2024-211186

Published: 2024

Journal Articles

Early-life infection depletes preleukemic cells in a mouse model of hyperdiploid B-cell acute lymphoblastic leukemia

Ali Farrokhi, Tanmaya Atre, Samuel Salitra, Maryam Aletaha, Ana Citlali Márquez, Matthew Gynn, Mario Fidanza, Sumin Jo, Nina Rolf, Karen Simmons, Jesus Duque-Afonso, Michael L. Cleary, Alix E. Seif, Tobias Kollmann, Soren Gantt, Gregor S. D. Reid

Blood (2024) 144 (8): 809–821.

https://doi.org/10.1182/blood.2024025038

Published: 2024

Includes: Supplemental data

Journal Articles

Toll-like Receptor-9 Agonist Reverses T Cell Exhaustion in a Murine Model of Pediatric B-ALL

Tanmaya Atre, Gregor S. D. Reid

Blood (2023) 142 (Supplement 1): 6815.

https://doi.org/10.1182/blood-2023-189892

Published: 2023

Journal Articles

Toll-like Receptor-3 Ligation Induces Pro-Survival Signaling in Pediatric Acute Lymphoblastic Leukemia

Tanmaya Atre, Ali Farrokhi, Gregor S. D. Reid

Blood (2021) 138 (Supplement 1): 3403.

https://doi.org/10.1182/blood-2021-153879

Published: 2021

Journal Articles

MRD Xenotransplantation Prospectively Identifies Treatment-Selected Acute Lymphoblastic Leukemia Subpopulations with Relapse-Initiating Potential

Nina Rolf, MDPhD, Angela Tsang, Lorraine Liu, Amanda Lorentzian, BSc, Pascal Leclair, MSc, Annette Patterson, PhD, Philipp Lange, PhD, Christopher Maxwell, PhD, Chinten J. Lim, PhD, Ramon Klein Geltink, PhD, Suzanne M. Vercauteren, MD PhD FRCPC, Gregor S. D. Reid, PhD

Blood (2020) 136 (Supplement 1): 12–13.

https://doi.org/10.1182/blood-2020-143408

Published: 2020

Journal Articles

Clinical and Laboratory Features Associated with Flow Cytometric CD49f Expression in Pediatric B Cell Acute Lymphoblastic Leukemia

Eric McGinnis, MD BSc, David Yang, BMLSc, Nina Rolf, MD PhD, Gregor S. D. Reid, PhD, Chinten J. Lim, PhD, Suzanne M. Vercauteren, MD PhD FRCPC

Blood (2019) 134 (Supplement_1): 5209.

https://doi.org/10.1182/blood-2019-123590

Published: 2019

Journal Articles

Integrin Activity Reduces Immunogenic Cell Death By Inhibiting Cell Surface Presentation of ERp57 and Calreticulin

Chi-Chao Liu, Pascal Leclair, Foujan Pedari, Monajemi Mahdis, Laura Sly, Gregor S. D. Reid, PhD, Chinten James Lim, PhD

Blood (2018) 132 (Supplement 1): 3927.

https://doi.org/10.1182/blood-2018-99-119550

Published: 2018

Journal Articles

Differential Effects of Pathogenic and Non-Pathogenic Early-Life Exposures on Acute Lymphoblastic Leukemia Progression in Eμ-RET Mice

Matthew Gynn, Mario Fidanza, Sumin Jo, Soren Gantt, Tobias R. Kollmann, Gregor S. D. Reid, PhD

Blood (2018) 132 (Supplement 1): 1422.

https://doi.org/10.1182/blood-2018-99-119718

Published: 2018

Journal Articles

Accounting for the Unique Molecular Landscape of Pediatric Malignancies Improves Target-Agent Pair Identification for Pediatric Precision Oncology

Amanda Lorentzian, BSc, Nina Rolf, MD PhD, Gregor S. D. Reid, PhD, Chinten James Lim, PhD, Christopher Maxwell, PhD, Philipp F Lange, PhD

Blood (2018) 132 (Supplement 1): 2829.

https://doi.org/10.1182/blood-2018-99-119934

Published: 2018

Journal Articles

Severe Sepsis As Immune Stimulation and Protection from Relapse of Childhood Acute Lymphoblastic Leukemia (ALL): Results from a Pilot Study and Validation of Events in a National Administrative Dataset

Alix E. Seif, MD, Viviane C. Cahen, Yimei Li, PhD, Caitlin Walfoort Elgarten, MD, Amanda M. Dinofia, MD, Jennifer J. Wilkes, MD, Lena Winestone, MD, Yuan-Shung V. Huang, MS, Julie C Fitzgerald, MD, Brian T Fisher, DO, Gregor S. D. Reid, PhD, Kelly D Getz, Richard Aplenc, MD

Blood (2017) 130 (Supplement 1): 3445.

https://doi.org/10.1182/blood.V130.Suppl_1.3445.3445

Published: 2017

Journal Articles

Noninvasive bioluminescent imaging of primary patient acute lymphoblastic leukemia: a strategy for preclinical modeling

David M. Barrett, Alix E. Seif, Carmine Carpenito, David T. Teachey, Jonathan D. Fish, Carl H. June, Stephan A. Grupp, Gregor S. D. Reid

Blood (2011) 118 (15): e112–e117.

https://doi.org/10.1182/blood-2011-04-346528

Published: 2011

Includes: Supplemental data

Journal Articles

Bioluminescent Tracking of Human and Mouse Acute Lymphoblastic Leukemia Reveals Potent Immunogenicity of Luciferase In Some Preclinical Models of Leukemia

David M Barrett, MD/PhD, Alix E Seif, MD, Carmine Carpenito, PhD, Eliza P Strong, Carl H. June, MD, Stephan A. Grupp, MD, PhD, Gregor S. D. Reid, PhD

Blood (2010) 116 (21): 2140.

https://doi.org/10.1182/blood.V116.21.2140.2140

Published: 2010

Journal Articles

Long-term protection from syngeneic acute lymphoblastic leukemia by CpG ODN-mediated stimulation of innate and adaptive immune responses

Alix E. Seif, David M. Barrett, Michael Milone, Valerie I. Brown, Stephan A. Grupp, Gregor S. D. Reid

Blood (2009) 114 (12): 2459–2466.

https://doi.org/10.1182/blood-2009-02-203984

Published: 2009

Journal Articles

mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemia

David T. Teachey, Cecilia Sheen, Junior Hall, Theresa Ryan, Valerie I. Brown, Jonathan Fish, Gregor S. D. Reid, Alix E. Seif, Robin Norris, Yueh J. Chang, Martin Carroll, Stephan A. Grupp

Blood (2008) 112 (5): 2020–2023.

https://doi.org/10.1182/blood-2008-02-137141

Published: 2008

Includes: Supplemental data

Journal Articles

In vivo control of acute lymphoblastic leukemia by immunostimulatory CpG oligonucleotides

Hisaki Fujii, Jacqueline D. Trudeau, David T. Teachey, Jonathan D. Fish, Stephan A. Grupp, Kirk R. Schultz, Gregor S. D. Reid

Blood (2006) 109 (5): 2008–2013.

https://doi.org/10.1182/blood-2006-02-002055

Published: 2006

Journal Articles

CpG stimulation of precursor B-lineage acute lymphoblastic leukemia induces a distinct change in costimulatory molecule expression and shifts allogeneic T cells toward a Th1 response

Gregor S. D. Reid, Kevin She, Luke Terrett, Michael R. Food, Jacqueline D. Trudeau, Kirk R. Schultz

Blood (2005) 105 (9): 3641–3647.

https://doi.org/10.1182/blood-2004-06-2468

Published: 2005

NARROW

High-Dimensional Single-Cell Analysis of Clinical-Grade Flow Cytometry Explains the Unpredictable Complex Shifts of Patient-Specific Immunophenotypes during B-ALL Relapse Progression

Early-life infection depletes preleukemic cells in a mouse model of hyperdiploid B-cell acute lymphoblastic leukemia

Toll-like Receptor-9 Agonist Reverses T Cell Exhaustion in a Murine Model of Pediatric B-ALL

Toll-like Receptor-3 Ligation Induces Pro-Survival Signaling in Pediatric Acute Lymphoblastic Leukemia

MRD Xenotransplantation Prospectively Identifies Treatment-Selected Acute Lymphoblastic Leukemia Subpopulations with Relapse-Initiating Potential

Clinical and Laboratory Features Associated with Flow Cytometric CD49f Expression in Pediatric B Cell Acute Lymphoblastic Leukemia

Integrin Activity Reduces Immunogenic Cell Death By Inhibiting Cell Surface Presentation of ERp57 and Calreticulin

Differential Effects of Pathogenic and Non-Pathogenic Early-Life Exposures on Acute Lymphoblastic Leukemia Progression in Eμ-RET Mice

Accounting for the Unique Molecular Landscape of Pediatric Malignancies Improves Target-Agent Pair Identification for Pediatric Precision Oncology

Severe Sepsis As Immune Stimulation and Protection from Relapse of Childhood Acute Lymphoblastic Leukemia (ALL): Results from a Pilot Study and Validation of Events in a National Administrative Dataset

Noninvasive bioluminescent imaging of primary patient acute lymphoblastic leukemia: a strategy for preclinical modeling

Bioluminescent Tracking of Human and Mouse Acute Lymphoblastic Leukemia Reveals Potent Immunogenicity of Luciferase In Some Preclinical Models of Leukemia

Long-term protection from syngeneic acute lymphoblastic leukemia by CpG ODN-mediated stimulation of innate and adaptive immune responses

mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemia

In vivo control of acute lymphoblastic leukemia by immunostimulatory CpG oligonucleotides

CpG stimulation of precursor B-lineage acute lymphoblastic leukemia induces a distinct change in costimulatory molecule expression and shifts allogeneic T cells toward a Th1 response

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only